Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Risk factors for surgical site infection in patients undergoing obstetrics and gynecology surgeries: A meta-analysis of observational studies

  • Zhan Yang,

    Roles Formal analysis, Software, Supervision

    Affiliations Medical Department, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China, Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, Sichuan, China

  • Dong Wang,

    Roles Data curation, Supervision

    Affiliations Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, Sichuan, China, Nosocomial Infection Management Department, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China

  • Min Yang,

    Roles Formal analysis, Resources

    Affiliation Department of Laboratory Medicine, Chengdu Jinniu District Center for Disease Prevention and Control, Chengdu, Sichuan, China

  • Jianjun Deng,

    Roles Data curation, Supervision

    Affiliations Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, Sichuan, China, Nosocomial Infection Management Department, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China

  • Yin Liu

    Roles Writing – original draft, Writing – review & editing

    614958117@qq.com

    Affiliations Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, Sichuan, China, Nosocomial Infection Management Department, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China

Abstract

Objective

The aim of this study was to identify the risk factors for surgical site infection (SSI) in patients undergoing obstetrics and gynecology surgeries through meta-analysis.

Methods

Relevant original studies published from January 1945 to May 2023 were searched the CBM, PubMed, Embase, WOS, CNKI, Wanfang, vip, and Cochrane Library databases. Studies eligible were evaluated by two investigators following Newcastle-Ottawa Scale(NOS) criteria. Review Manager 5.3 software was used to analyse the combined effect sizes and test for heterogeneity, and Stata 14.0 software’s Begg’s Test and Egger’s Test were used to test for bias.

Results

13 case-control articles, including 860 cases in the case group and 13574 cases in the control group, met the inclusion criteria. Eventually, Our meta-analysis showed that SSI in patients undergoing obstetrics and gynecology surgeries was correlated with body mass index (BMI)≥24 (OR = 2.66; P < 0.0001), malignant lesions (OR = 4.65; P < 0.0001), operating time≥60min (OR = 2.58; P < 0.0001), intraoperative bleeding≥300ml (OR = 2.54; P < 0.0001), retained urinary catheter (OR = 4.45; P < 0.0001), and vaginal digital examination≥3times (OR = 2.52; P < 0.0001).

Conclusion

In this study, BMI≥24, intraoperative bleeding≥300ml, malignant lesions, operating time≥60min, retained urinary catheter, and vaginal digital examination≥3times were considered as independent risk factors for SSI in obstetrics and gynecology surgery. It is recommended that scholars be rigorous in designing the experimental process when conducting case-control or experimental studies in order to improve the quality of the study. Controlling patients’ weight before obstetrical and gynecological surgery, shortening the operation time intraoperatively, and strictly controlling the indications of vaginal digital examination and retained urinary catheter can effectively reduce the incidence of SSI.

Introduction

Hysterectomy is one of the three most commonly performed procedures in gynecology [1], while cesarean section is the most commonly performed procedure in obstetrics and constitutes approximately 40% of all deliveries in China [2, 3]. Incisions in obstetrics and gynecology surgery are often placed on the skin, vulva, vagina, and other places where a large number of microorganisms exist. These incisions are extremely susceptible to infection. At the same time, infection is associated with increased hospitalization time and elevated health care costs [4]. Of the infections, SSI, which affects surgical therapeutic outcomes, is the most prevalent hospital-based infection [4]. In China, the incidence of SSI after obstetric and gynecologic surgery is 4.62% [5]. The incidence of SSI after hysterectomy ranged from 2.3% to 8.1% [68], and the incidence of SSI after cesarean section ranged from 3% to 16% [911]. However, the risk factors for SSI are complex and difficult to identify. Current findings on risk factors in the literature are often limited by small sample sizes and weak statistical power. The aim of this study was to provide an evidence-based theoretical basis as well as scientific recommendations for the prevention of surgical site infections in obstetrics and gynecological surgery by combining and analyzing the outcome data from several related publications.

Research methodology

Search strategy

Eight databases were searched in CBM, Wanfang, CNKI, VIP, Pubmed, WOS, Cochrane Library, and Embase according to the search strategy (inclusion date:May 12, 2023). The search terms will follow the standard PICO guideline (population, intervention, comparator, outcome) and were developed according to disease category (gynecological surgery or obstetric surgery) and study purpose (surgical site infection). The search formula was developed by combining free words with subject terms, and the Medical Subject Headings (MeSH) terms were searched in the Pubmed database [12, 13].

Inclusion criteria and exclusion criteria

The selection of studies was first performed on the basis of titles and abstracts. Then two authors (Yin Liu and Dong Wang) independently screened the full text of the identified papers using the following inclusion criteria: (1) studies must meet the National Healthcare Safety Network’s definition of SSI: a wound infection that occurs within 30 days of an operative procedure or within a year if an implant is left in place and the infection is thought to be secondary to surgery [14]; (2) Statistics must be included in the multi-factor analysis after univariate analysis of significant indicators; (3) studies providing effect estimates of the relative risks (RRs) or odds ratios (ORs) with 95% confidence intervals (CIs); (4) case-control or cohort studies.

Review articles, conference abstracts, animal experiments, meta-analyses, and studies with insufficient or overlapping data were excluded from this study. Mediolateral episiotomy, vulval surgeries, repair of perineal tears, hysteroscopic surgery and cervical surgery, were also excluded at the same time.

Quality assessment

The quality of all the included studies was evaluated by NOS based on the three modules: the selection of case group and control group (0–4 points), inter-comparability of groups (0–2 points), exposure and outcomes (0–3 points), with a maximum score of 9. The studies with NOS scores ≥ 6 were considered relatively higher quality [15].

Data extraction

For all eligible studies, the following variables were extracted by two authors (Yin Liu and Dong Wang): (1) the first author’s name; (2) publication year; (3) year of the study; (4) country; (5) risk factors; (6) surgical types; (7) study type; (8) statistical methods; (9) numbers of cases and controls; and (10) estimates of odds ratios (ORs) or relative risks (RRs). Any disagreement was settled by the third reviewer (Zhan Yang).

Statistical analysis

All the statistical analyses were performed with RevMan 5.3 (The Nordic Cochrane Centre, Copenhagen, Denmark) and Stata 14.0 (Stata Corporation, College Station, TX). For all risk factors in our study, adjusted ORs and 95% CIs were extracted from the original studies. A two-tail P value less than 0.05 was considered significant. Heterogeneity was tested by the Q-test (with significance set at P < 0.10) and I2 statistics (with I2 > 50% implying heterogeneity). In the case of significant heterogeneity, we use sensitivity analysis to recognize the potential contribution of each study to the heterogeneity by removing one study at a time. If heterogeneity still existed, random-effects models were used; otherwise, fixed-effects models were used.The outcomes of the meta-analysis were summarized by the forest plot.

Result

Study selection and evaluation

A total of 11429 potentially eligible studies were identified by the initial database search, of which 3701 were included after excluding those published before 2004, duplicates, reviews, animal studies, patents, and commentaries. After screening titles and abstracts, 42 articles were included. After reading the full article carefully, 13 retrospective case control studies that were published between 2017 and 2023 were included (Fig 1). The outcomes of the NOS score for these 13 articles were as follows: One study scored 8; five studies scored 7; and seven studies scored 6. Literature with an assessment score of 5 or more was included in the meta-analysis, and all 13 papers were included in the meta-analysis. Detailed information about those 13 studies is presented in Table 1.

Meta-analysis

Combined analysis of effect sizes.

A fixed model was selected to analyze anemia, BMI, malignant lesions, surgery time, intraoperative bleeding, diabetes, retained urinary catheter, and vaginal digital examination, and the results are shown sequentially in Figs 29.

As can be seen from Figs 29: BMI, intraoperative bleeding, retained urinary catheter, and vaginal digital examination were independent risk factors for surgical site infection after obstetrical and gynecological surgery (p < 0.05); there was significant heterogeneity in the results of the surgery time, malignant lesion, diabetes and anemia (I2 > 50%, p < 0.1), and sensitivity analysis needs to be continued.

Sensitivity analysis.

The heterogeneity of surgery time(Fig 10) was significantly reduced after removing Weng YR 2018. Xie ZY 2019 in the malignant lesion study(Fig 11) and Ye Q 2019 in the diabetes study(Fig 12) were the main causes of heterogeneity, and the meta-analysis was performed again after removing the literature that caused heterogeneity, which yielded: surgery time and malignant lesions were independent risk factors for SSI in obstetrical and gynecological surgery (p < 0.05). In studies involving anemia(Fig 13), the result was I2 ≥ 99%, regardless of which study was deleted.

Bias test.

Separate tests of bias for BMI, operative time, intraoperative bleeding, retained urinary catheter, vaginal digital examination, and malignant lesions yielded: operative time (t = 1.99, P > |t| = 0.094 > 0.05), intraoperative bleeding (t = 1.19, P > |t| = 0.320 > 0.05), retained urinary catheter (t = -0.47, P > |t| = 0.721 > 0.05), vaginal digital examination (t = 1.13, P > |t| = 0.461 > 0.05), and malignant lesions (z = 1.00, Pr > |z| = 0.317 > 0.05) were not publication biased. There was a mild publication bias in the BMI funnel plot (Fig 14) (t = 3.72, P > |t| = 0.01 < 0.05). The asymmetric funnel plot was processed by the cut-and-patch method, and the symmetry of the funnel plot could be ensured and publication bias eliminated by the three points of the square in Fig 15, indicating the need to include future effect size studies with results close to those of Arakaki Y 2019, Xu CW 2020, and Xie ZY 2017 (Fig 15).

Discussion

SSI is one of the most common complications after obstetric and gynecologic surgery [29, 30]. Previous studies have identified many risk factors, including BMI, operating time, vaginal digital examination, intraoperative bleeding, diabetes, obesity, and malignant lesions [3136]. However, these studies usually focused on only some of the risk factors and lacked a comprehensive quantitative summary of all the risk factors for SSI in obstetric and gynecologic surgery. A total of 13 articles were included in this study, including 860 cases in the case group and 13574 cases in the control group. Eventually, our meta-analysis showed that BMI≥24 (OR = 2.66; P < 0.0001), malignant lesions (OR = 4.65; P < 0.0001), operating time≥60min (OR = 2.58; P < 0.0001), intraoperative bleeding≥300ml (OR = 2.54; P < 0.0001), retained urinary catheter (OR = 4.45; P < 0.0001), and vaginal digital examination≥3times (OR = 2.52; P < 0.0001) were independent risk factors for SSIs in obstetrics and gynecology surgery.

The greatest risk factor for SSI in obstetric and gynecologic surgery is malignant lesions (OR = 4.65), which increase the likelihood of SSI by 365%. Malignant lesions have long been recognized as a major source of postoperative infections [37, 38]. The immune system is generally compromised in patients with malignant tumors [39]. This impairment in the primary immune function directly results from the tumor’s pervasive influence on the natural defense mechanisms [40]. In addition, standard therapeutic interventions for tumors, including surgery, chemotherapy, and radiation therapy, also lead to weakened immune function [41]. The second largest risk factor is retained urinary catheter (OR = 4.45), which has a 355% increased likelihood of SSI. Retaining a urinary catheter is, on the one hand, an invasive operation itself, and on the other hand, the friction of the tube in the urethra can cause inflammation [4244].

The study by Li Jing et al. also concluded that BMI, operating time, vaginal digital examination, and intraoperative bleeding were risk factors for SSI in obstetric and gynecologic surgery, but that article did not give specific values for BMI, operating time, or intraoperative bleeding. The results of this study showed that anemia and diabetes mellitus were not risk factors for SSI in obstetric and gynecologic surgery, which is inconsistent with the findings of Li Runrong et al. The possible reason is that BMI and diabetes may be interlinked, and obesity-induced insulin resistance is one of the major sources of type 2 diabetes [4548]. Therefore, most of the studies selected only one of the two factors for analysis. Only three of the 13 articles included in this study analyzed diabetes, and more data support is needed for a more scientific conclusion.

To ensure the reliability of the conclusions of the analysis and the homogeneity of the study outcomes, three aspects of the included literature, namely, clinical research direction, experimental design methodology, and statistics [49], were strictly controlled during the literature screening process in this study [50, 51]. In terms of clinical study orientation, confounding factors such as perineal surgeries were excluded from this study because the female lower genital tract is connected to the outside world and hosts a variety of colonizing bacteria, mycoplasma, chlamydia, and pseudofilamentous yeasts [52]. Although surgical sites were excluded, there are many different types of obstetric and gynecologic surgery, including total laparoscopic hysterectomy, abdominal hysterectomy, and total vaginal hysterectomy, etc. The type of surgery may also be an influencing factor for SSI [53], and this point was not explored in this article.

Conclusion

In this study, BMI≥24, intraoperative bleeding≥300ml, malignant lesions, operating time≥60min, retained urinary catheter, and vaginal digital examination≥3times were considered as independent risk factors for SSI in obstetrics and gynecology surgery.According to the results of this study, in order to reduce the incidence of SSI in obstetrics and gynecology surgery, the medical staff should carry out a comprehensive assessment of the patient before the surgery and formulate a reasonable surgical program. In patients undergoing planned obstetric and gynecologic surgery, weight management should be done. Rational prophylactic use of antimicrobials before performing surgery for patients with malignant lesions. Surgical methods, surgical instruments, and experienced medical staff should be rationally selected to minimize the surgical incision in order to shorten the operation time and reduce intraoperative bleeding. When estimating the progress of labor, focus on the observation of the mother’s condition, such as the contraction of the uterus, the heartbeat of the fetus, etc., and reduce the number of vaginal digital examinations. Post-operative observation of the patient should be strengthened, and the catheter should be removed as early as possible.

Acknowledgments

Thanks to all the researchers who contributed to this paper and provided advice.

Registration and protocol: This study is registered with prospero under the registration number: CRD42023425441.

References

  1. 1. Kaboré B, Soudouem G, Seck I, Millogo T, Evariste Yaméogo WM, Kouanda S: A case-control study of risk factors for surgical site infection after cesarean delivery in eastern Burkina Faso. Int J Gynaecol Obstet 2016, 135 Suppl 1:S107–s110. pmid:27836076
  2. 2. Gong S-P, Guo H-X, Zhou H-Z, Chen L, Yu Y-H: Morbidity and risk factors for surgical site infection following cesarean section in Guangdong Province, China. The journal of obstetrics and gynaecology research 2012, 38(3):509–515. pmid:22353388
  3. 3. Hamilton BE, Martin JA, Osterman MJ, Curtin SC, Matthews TJ: Births: Final Data for 2014. Natl Vital Stat Rep 2015, 64(12):1–64. pmid:26727629
  4. 4. de Lissovoy G, Fraeman K, Hutchins V, Murphy D, Song D, Vaughn BB: Surgical site infection: incidence and impact on hospital utilization and treatment costs. Am J Infect Control 2009, 37(5):387–397. pmid:19398246
  5. 5. Betrán AP, Merialdi M, Lauer JA, Bing-Shun W, Thomas J, Van Look P, et al.: Rates of caesarean section: analysis of global, regional and national estimates. Paediatr Perinat Epidemiol 2007, 21(2):98–113. pmid:17302638
  6. 6. Zhang X, Yang Y, Liu P, Wang P, Li X, Zhu J, et al.: Identification of Risk Factors and Phenotypes of Surgical Site Infection in Patients After Abdominal Surgery. Ann Surg 2023, 278(5):e988–e994. pmid:37309899
  7. 7. Pathak A, Mahadik K, Swami MB, Roy PK, Sharma M, Mahadik VK, et al.: Incidence and risk factors for surgical site infections in obstetric and gynecological surgeries from a teaching hospital in rural India. Antimicrob Resist Infect Control 2017, 6:66. pmid:28630690
  8. 8. Mehtar S, Wanyoro A, Ogunsola F, Ameh EA, Nthumba P, Kilpatrick C, et al.: Implementation of surgical site infection surveillance in low- and middle-income countries: A position statement for the International Society for Infectious Diseases. Int J Infect Dis 2020, 100:123–131. pmid:32712427
  9. 9. Abdelraheim AR, Gomaa K, Ibrahim EM, Mohammed MM, Khalifa EM, Youssef AM, et al.: Intra-abdominal infection (IAI) following cesarean section: a retrospective study in a tertiary referral hospital in Egypt. BMC Pregnancy Childbirth 2019, 19(1):234. pmid:31286872
  10. 10. Kawakita T, Landy HJ: Surgical site infections after cesarean delivery: epidemiology, prevention and treatment. Matern Health Neonatol Perinatol 2017, 3:12. pmid:28690864
  11. 11. Mekonnen AG, Mittiku YM: Surgical site infection and its association with rupture of membrane following cesarean section in Africa: a systematic review and meta-analysis of published studies. Matern Health Neonatol Perinatol 2021, 7(1):2. pmid:33388090
  12. 12. Dhammi IK, Kumar S: Medical subject headings (MeSH) terms. Indian J Orthop 2014, 48(5):443–444. pmid:25298548
  13. 13. Richter RR, Austin TM: Using MeSH (medical subject headings) to enhance PubMed search strategies for evidence-based practice in physical therapy. Phys Ther 2012, 92(1):124–132. pmid:21979271
  14. 14. Horan TC, Andrus M, Dudeck MA: CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008, 36(5):309–332. pmid:18538699
  15. 15. Bramer WM, de Jonge GB, Rethlefsen ML, Mast F, Kleijnen J: A systematic approach to searching: an efficient and complete method to develop literature searches. J Med Libr Assoc 2018, 106(4):531–541. pmid:30271302
  16. 16. Arakaki YN, T. Kinjyo Y. Shimoji Y. Taira Y. Nakamoto T. Wakayama , et al.: Surgical site infection in patients with endometrial cancer undergoing open surgery. European journal of gynaecological oncology 2019, 40(4).
  17. 17. Q. Y: [Analysis of the characteristics and risk factors of incisional infection after caesarean section in elderly women]. Pharmaceutical evaluation 2019, 16(2).
  18. 18. XJ M, LQ C, Y L: [Analysis of surgical site infections after hysterectomy and risk factors]. Preventive Medicine 2017, 29(11):1160–1162.
  19. 19. W FF, JW Z, W XY: [Risk factors affecting incisional infections in hysterectomy patients and countermeasures to prevent them]. Chinese Journal of Maternal and Child Health 2020, 35(03):442–444.
  20. 20. CW X: [Investigation of the distribution of pathogenic bacteria and risk factors for surgical site infections in caesarean sections]. Chinese Journal of Health Inspection 2020, 30(16):2021–2024.
  21. 21. YR W, AZ F, C S, ML H, HX L: [Pathogenetic characteristics and factors influencing postoperative incisional infections in women undergoing caesarean section]. Chinese Journal of Hospital Infection 2018, 28(07):1068–1071.
  22. 22. ZY X, Y X, Sun J HY, ZL Y, H Y: [Incisional infection after secondary caesarean section and its risk factors]. Chinese Journal of Disinfection 2017, 34(01):49–51.
  23. 23. G Z, WC C, CH L, F L, L H, QH T, al e: [Risk factors for surgical site infection after total hysterectomy in patients with gynecologic malignancies]. Chinese Journal of Infection Control 2021, 20(07):602–606.
  24. 24. QZ Z: [Analysis of the characteristics of pathogenic bacteria and risk factors for postoperative incisional infections in women undergoing caesarean section]. Chinese Journal of Health Inspection 2019, 29(09):1105–1107.
  25. 25. JY W, YD L, WW L, DX W, C S, GY M: [A study on the factors influencing incisional infections after caesarean section]. Journal of Rational Clinical Use of Drugs 2019, 12(30):8–10.
  26. 26. Abdel Jalil MH, Abu Hammour K, Alsous M, Awad W, Hadadden R, Bakri F, et al.: Surgical site infections following caesarean operations at a Jordanian teaching hospital: Frequency and implicated factors. Sci Rep 2017, 7(1):12210. pmid:28939862
  27. 27. Li L, Cui H: The risk factors and care measures of surgical site infection after cesarean section in China: a retrospective analysis. BMC Surg 2021, 21(1):248. pmid:34011324
  28. 28. Xie ZY, Li YF, Meng GL, Xiong Y, Li YJ, Chen YQ: [Correlation between Asymptomatic Bacteriuria and Surgical Site Infection in Middle-aged and Elderly Patients Undergoing Open Hysterectomy]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2019, 41(5):630–635. pmid:31699193
  29. 29. Tsai R, Raptis D, Raptis C, Mellnick VM: Complications After Gynecologic and Obstetric Procedures: A Pictorial Review. Curr Probl Diagn Radiol 2018, 47(3):189–199. pmid:28669430
  30. 30. Yan L, Rong F, Gao M, Chen G, Su Y, Xing L, et al.: Complications and feasibility analysis of ambulatory surgery for gynecological diseases in China. Medicine (Baltimore) 2021, 100(1):e23995. pmid:33429761
  31. 31. Saadia Z: Urinary Problems Amongst Gynecological Consultations. Association Between Prolapse, Gynecological Surgery and Diabetes. Med Arch 2015, 69(5):315–318.
  32. 32. Cheadle WG: Risk factors for surgical site infection. Surg Infect (Larchmt) 2006, 7 Suppl 1:S7–11. pmid:16834549
  33. 33. Bolton L: Surgical Site Infection in Cancer Patients. Wounds 2021, 33(10):260–262. pmid:34735363
  34. 34. Martin ET, Kaye KS, Knott C, Nguyen H, Santarossa M, Evans R, et al.: Diabetes and Risk of Surgical Site Infection: A Systematic Review and Meta-analysis. Infect Control Hosp Epidemiol 2016, 37(1):88–99. pmid:26503187
  35. 35. Migdal AL, Fortin-Leung C, Pasquel F, Wang H, Peng L, Umpierrez GE: Inpatient Glycemic Control With Sliding Scale Insulin in Noncritical Patients With Type 2 Diabetes: Who Can Slide? J Hosp Med 2021, 16(8):462–468. pmid:34328842
  36. 36. Blumenthal KG, Ryan EE, Li Y, Lee H, Kuhlen JL, Shenoy ES: The Impact of a Reported Penicillin Allergy on Surgical Site Infection Risk. Clin Infect Dis 2018, 66(3):329–336. pmid:29361015
  37. 37. Hirakawa H, Hasegawa Y, Hanai N, Ozawa T, Hyodo I, Suzuki M: Surgical site infection in clean-contaminated head and neck cancer surgery: risk factors and prognosis. Eur Arch Otorhinolaryngol 2013, 270(3):1115–1123. pmid:22865106
  38. 38. Dias TA, Fernandes DR, Dos Santos BN, Dos Reis PED, Margatho AS, Silveira R: Dressing to prevent surgical site infection in adult patients with cancer: a systematic review with meta-analysis. Support Care Cancer 2022, 31(1):11. pmid:36512091
  39. 39. Iocca O, Copelli C, Ramieri G, Zocchi J, Savo M, Di Maio P: Antibiotic prophylaxis in head and neck cancer surgery: Systematic review and Bayesian network meta-analysis. Head Neck 2022, 44(1):254–261. pmid:34741354
  40. 40. Dhatchinamoorthy K, Colbert JD, Rock KL: Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation. Front Immunol 2021, 12:636568. pmid:33767702
  41. 41. Hegde PS, Chen DS: Top 10 Challenges in Cancer Immunotherapy. Immunity 2020, 52(1):17–35. pmid:31940268
  42. 42. McGregor TB, Sharda R: Retained Urethral Catheter Secondary to Placement in Proximal Ureter. Case Rep Urol 2016, 2016:9178645. pmid:27144050
  43. 43. Adebamowo CA, Okeke LI: The retained urinary catheter. Trop Geogr Med 1993, 45(4):186–188. pmid:8236474
  44. 44. Feneley RC, Hopley IB, Wells PN: Urinary catheters: history, current status, adverse events and research agenda. J Med Eng Technol 2015, 39(8):459–470. pmid:26383168
  45. 45. Schernthaner GH, Schernthaner G: Insulin resistance and inflammation in the early phase of type 2 diabetes: potential for therapeutic intervention. Scand J Clin Lab Invest Suppl 2005, 240:30–40. pmid:16112958
  46. 46. Gordon PS, Farkas GJ, Gater DR Jr., Neurogenic Obesity-Induced Insulin Resistance and Type 2 Diabetes Mellitus in Chronic Spinal Cord Injury. Top Spinal Cord Inj Rehabil 2021, 27(1):36–56.
  47. 47. Tataranni PA: Pathophysiology of obesity-induced insulin resistance and type 2 diabetes mellitus. Eur Rev Med Pharmacol Sci 2002, 6(2–3):27–32. pmid:12708607
  48. 48. Goodpaster BH, Kelley DE: Skeletal muscle triglyceride: marker or mediator of obesity-induced insulin resistance in type 2 diabetes mellitus? Curr Diab Rep 2002, 2(3):216–222. pmid:12643176
  49. 49. Wang XM, Zhang XR, Li ZH, Zhong WF, Yang P, Mao C: A brief introduction of meta-analyses in clinical practice and research. J Gene Med 2021, 23(5):e3312. pmid:33450104
  50. 50. Ferreyro BL, Patino CM, Ferreira JC: Meta-analyses: a primer for clinicians. J Bras Pneumol 2021, 46(6):e20200609. pmid:33439929
  51. 51. Waltz PK, Zuckerbraun BS: Surgical Site Infections and Associated Operative Characteristics. Surg Infect (Larchmt) 2017, 18(4):447–450. pmid:28448197
  52. 52. John H, Nimeri A, Ellahham S: Improved Surgical Site Infection (SSI) rate through accurately assessed surgical wounds. BMJ Qual Improv Rep 2015, 4(1). pmid:26734358
  53. 53. Utsumi M, Yamada T, Yamabe K, Katsura Y, Fukuchi N, Fukunaga H, et al.: Differences in risk factors for surgical site infection between laparotomy and laparoscopy in gastrointestinal surgery. PLoS One 2022, 17(9):e0274887. pmid:36121818